Compounds > 1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone
Page last updated: 2024-09-03

1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone and Epilepsy

1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone has been researched along with Epilepsy in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Baldwin, A; Boberska, J; Claus, SP; Damstra-Oddy, J; Finch, P; Glyn, S; Greene, NDE; Harvey, RJ; Harwood, A; Leung, KY; McNeish, AJ; Müller-Taubenberger, A; Patra, PH; Perry, CJ; Piscitelli, F; Sharma, D; Stewart, B; Thompson, C; Warren, EC; Whalley, BJ; Williams, CM; Williams, RSB1
Damstra-Oddy, J; Schaf, J; Williams, RSB1
Damstra-Oddy, J; Dooves, S; Heine, VM; Lugarà, E; Schaf, J; Walker, MC; Warren, EC; Williams, RSB1
Kelly, E; Sharma, D; Wilkinson, CJ; Williams, RSB1
Walker, MC; Williams, RS1
Bialer, M; Chang, P; Deranieh, RM; Dham, M; Greenberg, ML; Hoeller, O; Orabi, B; Shimshoni, JA; Walker, MC; Williams, RS; Yagen, B1

Reviews

2 review(s) available for 1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone and Epilepsy

ArticleYear
Dictyostelium discoideum as a pharmacological model system to study the mechanisms of medicinal drugs and natural products.
    The International journal of developmental biology, 2019, Volume: 63, Issue:8-9-10

    Topics: Animals; Anti-Infective Agents; Bacterial Infections; Biological Products; Bipolar Disorder; Caffeine; Dictyostelium; Drug Discovery; Epilepsy; Flavonoids; Humans; Models, Animal; Models, Biological; Neoplasms

2019
The search for better epilepsy treatments: from slime mould to coconuts.
    Biochemical Society transactions, 2013, Volume: 41, Issue:6

    Topics: Animals; Anticonvulsants; Cocos; Dictyostelium; Drug Discovery; Epilepsy; Humans; Valproic Acid

2013

Other Studies

4 other study(ies) available for 1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone and Epilepsy

ArticleYear
A new mechanism for cannabidiol in regulating the one-carbon cycle and methionine levels in Dictyostelium and in mammalian epilepsy models.
    British journal of pharmacology, 2020, Volume: 177, Issue:4

    Topics: Animals; Anticonvulsants; Cannabidiol; Carbon Cycle; Dictyostelium; Epilepsy; Humans; Lennox Gastaut Syndrome; Methionine; Rats

2020
Decanoic acid inhibits mTORC1 activity independent of glucose and insulin signaling.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 09-22, Volume: 117, Issue:38

    Topics: Adaptor Proteins, Signal Transducing; Animals; Astrocytes; Cell Cycle Proteins; Cells, Cultured; Decanoic Acids; Dictyostelium; Epilepsy; Glucose; Hippocampus; Humans; Insulin; Mechanistic Target of Rapamycin Complex 1; Peptide Initiation Factors; Phosphorylation; Rats

2020
Diacylglycerol kinase (DGKA) regulates the effect of the epilepsy and bipolar disorder treatment valproic acid in
    Disease models & mechanisms, 2018, 08-21, Volume: 11, Issue:9

    Topics: Amino Acid Sequence; Anticonvulsants; Bipolar Disorder; Diacylglycerol Kinase; Dictyostelium; Diglycerides; Epilepsy; Green Fluorescent Proteins; Lithium; Models, Biological; Mutation; Valproic Acid

2018
The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium.
    Disease models & mechanisms, 2012, Volume: 5, Issue:1

    Topics: Animals; Anticonvulsants; Dictyostelium; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Inositol; Models, Biological; Mutation; Phosphatidylinositol 3-Kinases; Phosphatidylinositols; Rats; Signal Transduction; Time Factors; Valproic Acid

2012